Evidence map›Paper›PMID 30202793›Full record

ArticleAdvances in radiation oncology

Racial disparities in guideline-concordant cancer care and mortality in the United States.

Penny Fang, Weiguo He, Daniel Gomez, Karen E Hoffman, Benjamin D Smith, Sharon H Giordano, Reshma Jagsi, Grace L Smith

Abstract read
In one paragraph

Article in Advances in radiation oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Diminishing Returns Among Black Patients With Cancer: The Intersection of Race and Neighborhood Socioeconomic Status.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026
    Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Quality of Treatment Selection for Medicare Beneficiaries With Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Article
  11. Article
  12. Institutional Costs of Guideline-Concordant Care Non-Receipt among Women with Breast Cancer.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Penny FangDepartment of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas.
Weiguo HeDepartment of Health Services Research, The University of Texas, MD Anderson Cancer Center, Houston, Texas.
Daniel GomezDepartment of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas.
Karen E HoffmanDepartment of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas.
Benjamin D SmithDepartment of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas.
Sharon H GiordanoDepartment of Health Services Research, The University of Texas, MD Anderson Cancer Center, Houston, Texas.
Reshma JagsiDepartment of Radiation Oncology, The University of Michigan, Ann Arbor, Michigan.
Grace L SmithDepartment of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas.

Funding

Economic Strain and Resilience in Cancer Patients: Assessing Patient-Reported Measures of the Burdens of TreatmentK07CA211804 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SMITH, GRACE · 2016 to 2020
$853k
NCI NIH HHS K07 CA211804
6 · The paper itself

Abstract

purposeWe identified the frequency of racial disparities in guideline-concordant cancer care for select common disease sites in the United States and the impact of guideline concordance on mortality disparities. METHODS AND MATERIALS: Using Surveillance, Epidemiology, and End Results Medicare data, we evaluated patients age >65 years of black or non-Hispanic white race who were diagnosed with stage III breast (n = 3607), stage I (n = 14,605) or III (n = 15,609) non-small cell lung, or stage III prostate (n = 3548) cancer between 2006 and 2011. Chemotherapy, surgery, and radiation therapy (RT) treatments were identified using claims data. Pearson χ

resultsBlack patients were less likely to receive guideline-concordant curative treatment than non-Hispanic white patients for stage III breast cancer postmastectomy RT (53% black, 61% white;

conclusionsRacial disparities in the receipt of curative cancer therapy impacted racial mortality disparities across multiple cancer sites. Benchmarking adherence to guideline-concordant care could represent an opportunity to stimulate improvements in disparities in cancer treatment and survival.

Identifiers

PMID30202793
PMCPMC6128037

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.